glutathione als in the Nervous System as a Potential Therapeutic Target to Control the Development and Progression of Amyotrophic Lateral Sclerosis Neuro-Health Protocol with AKG Liquid

S.SharmaA.SainiM.YangY.AwasthiS.ZimniakP.AwasthiY

Antioxidants 9(20):911

Keep inflammation low by treating gently and not over-stamping

Note on humans: These benefits are not established in humans no completed human efficacy trials of MOTS-c exist [8]

Fourth, clinical translational potential is underdeveloped: there is a lack of clinical cohort data to confirm whether ferroptosis biomarkers (e.g., GPX4 downregulation and lipid peroxide accumulation) are elevated in kidney stone patients, and preclinical studies have not addressed whether targeting ferroptosis can reduce stone formation or recurrence (rather than just protecting tubular cells in vitro )